These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29079654)

  • 1. Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy.
    Lee H; Hodi FS; Giobbie-Hurder A; Ott PA; Buchbinder EI; Haq R; Tolaney S; Barroso-Sousa R; Zhang K; Donahue H; Davis M; Gargano ME; Kelley KM; Carroll RS; Kaiser UB; Min L
    Cancer Immunol Res; 2017 Dec; 5(12):1133-1140. PubMed ID: 29079654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.
    Ariyasu H; Inaba H; Ota T; Yamaoka H; Furukawa Y; Iwakura H; Doi N; Yamamoto Y; Akamizu T
    In Vivo; 2018; 32(2):345-351. PubMed ID: 29475919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
    Yamauchi I; Sakane Y; Fukuda Y; Fujii T; Taura D; Hirata M; Hirota K; Ueda Y; Kanai Y; Yamashita Y; Kondo E; Sone M; Yasoda A; Inagaki N
    Thyroid; 2017 Jul; 27(7):894-901. PubMed ID: 28537531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyroid dysfunctions secondary to cancer immunotherapy].
    Cugnet Anceau C; Abeillon J; Maillet D; Borson-Chazot F; Disse E
    Bull Cancer; 2020 Feb; 107(2):262-271. PubMed ID: 31879018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders.
    Ma C; Hodi FS; Giobbie-Hurder A; Wang X; Zhou J; Zhang A; Zhou Y; Mao F; Angell TE; Andrews CP; Hu J; Barroso-Sousa R; Kaiser UB; Tolaney SM; Min L
    Cancer Immunol Res; 2019 Jul; 7(7):1214-1220. PubMed ID: 31088848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors.
    Iyer PC; Cabanillas ME; Waguespack SG; Hu MI; Thosani S; Lavis VR; Busaidy NL; Subudhi SK; Diab A; Dadu R
    Thyroid; 2018 Oct; 28(10):1243-1251. PubMed ID: 30132401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.
    Wu X; Giobbie-Hurder A; Liao X; Connelly C; Connolly EM; Li J; Manos MP; Lawrence D; McDermott D; Severgnini M; Zhou J; Gjini E; Lako A; Lipschitz M; Pak CJ; Abdelrahman S; Rodig S; Hodi FS
    Cancer Immunol Res; 2017 Jan; 5(1):17-28. PubMed ID: 28003187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders.
    Jannin A; Penel N; Ladsous M; Vantyghem MC; Do Cao C
    Crit Rev Oncol Hematol; 2019 Sep; 141():23-35. PubMed ID: 31202955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-onset immune-related adverse events involving the thyroid gland by immune checkpoint inhibitors in combination with chemotherapy: a case report and retrospective cohort study.
    Ueba Y; Yamauchi I; Hakata T; Fujita H; Okamoto K; Ikeda K; Ueda Y; Fujii T; Taura D; Inagaki N
    Endocr J; 2023 Mar; 70(3):323-332. PubMed ID: 36464271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index.
    Pollack R; Ashash A; Cahn A; Rottenberg Y; Stern H; Dresner-Pollak R
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32668461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and risk factors of programmed death-1 inhibitors associated with thyroid gland injury].
    Gong WW; Zhou FY; Guo QH
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):176-181. PubMed ID: 36740408
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients.
    Campredon P; Mouly C; Lusque A; Bigay-Game L; Bousquet E; Mazières J; Caron P
    Presse Med; 2019 Apr; 48(4):e199-e207. PubMed ID: 31005502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common thyroid disorders.
    Sakiyama R
    Am Fam Physician; 1988 Jul; 38(1):227-38. PubMed ID: 3293385
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular Pathways: Immune Checkpoint Antibodies and their Toxicities.
    Cousin S; Italiano A
    Clin Cancer Res; 2016 Sep; 22(18):4550-5. PubMed ID: 27435397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
    Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
    Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence?
    Colombo MP
    Clin Cancer Res; 2017 Oct; 23(20):5999-6001. PubMed ID: 29030331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert opinion on thyroid complications in immunotherapy.
    Illouz F; Drui D; Caron P; Do Cao C
    Ann Endocrinol (Paris); 2018 Oct; 79(5):555-561. PubMed ID: 30126627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid dysfunction induced by anti-PD-1 therapy is associated with a better progression-free survival in patients with advanced carcinoma.
    Lu Y; Li Q; Xu L; Zheng Y; Wang Y; Liu Y; Zhang R; Liao L; Dong J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16501-16510. PubMed ID: 37715029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.